Focus - A Research Study Of Cgrp In Migraine Patients
Have you been diagnosed with Migraine?
The FOCUS study is recruiting participants and aims to test an investigational medication for migraine.You may be able to take part in this research study if you are aged between 18 and 70 years old and have tried 2-4 types of preventive migraine treatments in the last 10 years, but they have not worked.
The study will last 50 weeks from start to finish. This includes nine visits to the study clinic: one for Screening to ensure you can take part in the study, followed by seven visits during a study Treatment period (every 4 weeks) and one selesai Follow-Up visit at 46 weeks.
During study visits, you will have various assessments and procedures carried out. These will include physical examinations, sample collections of blood, urine and saliva and written questionnaires. You will also be required to keep a daily electronic headache diary.
You could benefit from participation in this study by learning more about your migraine disorder and you may or may not experience an improvement in your symptoms. There are, however, always some potential risks with taking part in any clinical research study.
If you would like to request more information about the study, please contact the FOCUS study team on:
PharmaSite Research, Inc.
(410) 602-1440
Requesting information does not obligate you to take part in the study.
